<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03526458</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0252</org_study_id>
    <secondary_id>A539800</secondary_id>
    <secondary_id>SMPH/UROLOGY</secondary_id>
    <secondary_id>Protocol Version 10/30/2017</secondary_id>
    <nct_id>NCT03526458</nct_id>
  </id_info>
  <brief_title>Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones</brief_title>
  <official_title>Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the time to acceptable stone fragmentation&#xD;
      during clinical use of the holmium laser when using energy settings 0.2J vs 0.8J. The&#xD;
      hypothesis is that holmium laser energy settings 0.8J will require less time than lower&#xD;
      energy settings 0.2J for fragmenting urinary stones. The clinical practice is to treat&#xD;
      urinary stones until the stone is reduced to fragments ≤ 2 mm in size. This is determined by&#xD;
      using the laser fiber which is 273 microns to visually estimate the size of the resultant&#xD;
      fragments as described by Patel et al, J Endo 2014. Investigators will standardize the effect&#xD;
      of stone size by creating a ratio of stone size to treatment time. In this study, the&#xD;
      frequency is set at 15Hz. Thus, the study contains two arms: 0.2J&amp;15Hz, and 0.8J&amp;15Hz.&#xD;
      Patients will be randomized into the two groups by the ratio of 1:1.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The only interventions imposed on subjects as a result of this study are (1) pre-procedural&#xD;
      randomization to laser lithotripsy with either 0.2J or 0.8J energy setting, and (2) the use&#xD;
      of patient information in describing results. All the other activities are part of the&#xD;
      routine clinical practice in the department. Participation in the study will not alter the&#xD;
      patients' preoperative, or postoperative care. During surgery, patients' stones will be&#xD;
      treated in accordance with the routine clinical practice of fragmenting stones into small&#xD;
      pieces (&lt;2 mm). All patients enrolled will undergo routine post-operative follow up including&#xD;
      clinic appointments and imaging evaluation. Any complications will be recorded, reported, and&#xD;
      treated appropriately. A fixed frequency will be used (15Hz). Thus, the study contains two&#xD;
      arms: 0.2J&amp;15Hz, and 0.8J&amp;15Hz. Patients will be randomized into the two groups by the ratio&#xD;
      of 1:1. A total of 1 clinic visit (i.e., the stone surgery, approximately 5-6 hours,&#xD;
      depending on the duration of the surgery) is needed for this study.&#xD;
&#xD;
      The study procedures are:&#xD;
&#xD;
        1. A study team member who is affiliated with the patient's clinical care (e.g., the&#xD;
           surgeon) will initially approach the patients who are scheduled laser lithotripsy&#xD;
           treatment of urinary stones. (i.e. informed that there's a research study they may be&#xD;
           eligible for, and asked if they want to learn more about it).&#xD;
&#xD;
        2. If the patient is interested in the study, a member of the research team will approach&#xD;
           him/her for enrollment.&#xD;
&#xD;
        3. Once the consent form is obtained, patients' medical background will be reviewed for&#xD;
           inclusion/exclusion criteria. Patients who meet the inclusion criteria will be included&#xD;
           in the study; patients who do not meet the inclusion criteria will be excluded.&#xD;
&#xD;
        4. Patients will be randomized to either 0.2J&amp;15Hz or 0.8J&amp;15Hz (randomization ratio 1:1)&#xD;
           group.&#xD;
&#xD;
        5. Patients will undergo stone surgeries with the laser setting that they are randomized&#xD;
           to. The patient's stone(s) will be treated in accordance with the routine clinical&#xD;
           practice of fragmenting stone into small pieces (≤ 2mm). The faculty surgeon (i.e., Dr.&#xD;
           Nakada) will perform all surgeries.&#xD;
&#xD;
        6. Fragmentation time as well as other information (total surgery time, complications,&#xD;
           stone information, and number of stones treated) is collected.&#xD;
&#xD;
        7. After surgery, the patients will then continue on normal postoperative pathway.&#xD;
           Postoperative complications will be collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 30, 2019</start_date>
  <completion_date type="Actual">March 24, 2021</completion_date>
  <primary_completion_date type="Actual">March 24, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fragmentation Time</measure>
    <time_frame>up to 6 hours</time_frame>
    <description>The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Operative Time</measure>
    <time_frame>up to 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre-Operative Stone Size</measure>
    <time_frame>Retrospective review of health chart at Baseline</time_frame>
    <description>Pre-operative stone size (on pre-operative CT) will be reported in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Either Ureteral or Renal Location of Urinary Stone</measure>
    <time_frame>up to 6 hours</time_frame>
    <description>Urinary stone location will be classified as renal or ureter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Treated for Either Single or Multiple Urinary Stones</measure>
    <time_frame>up to 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Density of Urinary Stones</measure>
    <time_frame>up to 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm</measure>
    <time_frame>up to 6 hours</time_frame>
    <description>Size of fragments created will be assessed using the laser fiber size as a comparison.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Stone Ureter</condition>
  <condition>Stone;Renal</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Holmium:YAG laser: 0.2J&amp;15Hz</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Holmium:YAG laser: 0.8J&amp;15Hz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holmium:YAG laser</intervention_name>
    <description>Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
    <arm_group_label>Holmium:YAG laser: 0.2J&amp;15Hz</arm_group_label>
    <arm_group_label>Holmium:YAG laser: 0.8J&amp;15Hz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at least 18 years of age&#xD;
&#xD;
          -  Patients with urinary stones who require endoscopic treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients &lt; 18 years of age&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Pre-menopausal females who have not been on approved birth control for at least 1&#xD;
             month pre-operatively&#xD;
&#xD;
          -  Patients with stones known to be refractory to treatment with the holmium laser&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Nakada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2018</study_first_posted>
  <results_first_submitted>July 27, 2021</results_first_submitted>
  <results_first_submitted_qc>July 27, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 20, 2021</results_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Holmium Laser</keyword>
  <keyword>Laser setting</keyword>
  <keyword>Stone fragmentation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 30, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/58/NCT03526458/Prot_SAP_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 27, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/58/NCT03526458/ICF_003.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
        <group group_id="P2">
          <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Surgeries rescheduled or cancelled due to COVID</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Stone passed, surgery cancelled</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of equipment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
        <group group_id="B2">
          <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" spread="15.4"/>
                    <measurement group_id="B2" value="55.6" spread="13.1"/>
                    <measurement group_id="B3" value="53.6" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fragmentation Time</title>
        <description>The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)</description>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Fragmentation Time</title>
          <description>The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5" spread="19.2"/>
                    <measurement group_id="O2" value="7.9" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.012</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>16.6</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.4</ci_lower_limit>
            <ci_upper_limit>28.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Operative Time</title>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Operative Time</title>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.7" spread="20.6"/>
                    <measurement group_id="O2" value="64.3" spread="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.132</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>11.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>7.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.6</ci_lower_limit>
            <ci_upper_limit>26.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pre-Operative Stone Size</title>
        <description>Pre-operative stone size (on pre-operative CT) will be reported in millimeters.</description>
        <time_frame>Retrospective review of health chart at Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Pre-Operative Stone Size</title>
          <description>Pre-operative stone size (on pre-operative CT) will be reported in millimeters.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="5.2"/>
                    <measurement group_id="O2" value="9.2" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.654</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.7</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.4</ci_lower_limit>
            <ci_upper_limit>6.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Either Ureteral or Renal Location of Urinary Stone</title>
        <description>Urinary stone location will be classified as renal or ureter.</description>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Either Ureteral or Renal Location of Urinary Stone</title>
          <description>Urinary stone location will be classified as renal or ureter.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ureteral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.299</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Treated for Either Single or Multiple Urinary Stones</title>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Treated for Either Single or Multiple Urinary Stones</title>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Single</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.076</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Density of Urinary Stones</title>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Density of Urinary Stones</title>
          <units>Hounsfield units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="935.2" spread="367.9"/>
                    <measurement group_id="O2" value="924.7" spread="374.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.943</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>10.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>143.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-286</ci_lower_limit>
            <ci_upper_limit>306.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm</title>
        <description>Size of fragments created will be assessed using the laser fiber size as a comparison.</description>
        <time_frame>up to 6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
          <group group_id="O2">
            <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
            <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm</title>
          <description>Size of fragments created will be assessed using the laser fiber size as a comparison.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1mm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2mm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3mm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.185</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Within 30 days of the surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Holmium:YAG Laser: 0.2J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.2J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
        <group group_id="E2">
          <title>Holmium:YAG Laser: 0.8J&amp;15Hz</title>
          <description>Patients are assigned to treat stones with 0.8J&amp;15Hz of the holmium laser.&#xD;
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Shuang Li</name_or_title>
      <organization>University of Wisconsin, School of Medicine and Public Health, Department of Urology</organization>
      <phone>6082638336</phone>
      <email>lis@urology.wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

